News
ENDPQ
0.0006
NaN%
--
Endo International reports Q1 results; initiates FY24 outlook
Seeking Alpha · 05/31 08:33
Endo hit with $1.5B in fines, forfeiture related to distribution of opioid Opana
Seeking Alpha · 05/03 17:24
Weekly Report: what happened at ENDPQ last week (0422-0426)?
Weekly Report · 04/29 09:42
Weekly Report: what happened at ENDPQ last week (0415-0419)?
Weekly Report · 04/22 09:40
Weekly Report: what happened at ENDPQ last week (0408-0412)?
Weekly Report · 04/15 09:36
Weekly Report: what happened at ENDPQ last week (0401-0405)?
Weekly Report · 04/08 09:38
Weekly Report: what happened at ENDPQ last week (0325-0329)?
Weekly Report · 04/01 09:38
Weekly Report: what happened at ENDPQ last week (0318-0322)?
Weekly Report · 03/25 09:39
Endo gains OK for Chapter 11 bankruptcy reorgaanization
Seeking Alpha · 03/19 22:31
Weekly Report: what happened at ENDPQ last week (0311-0315)?
Weekly Report · 03/18 09:38
Weekly Report: what happened at ENDPQ last week (0304-0308)?
Weekly Report · 03/11 09:38
Weekly Report: what happened at ENDPQ last week (0226-0301)?
Weekly Report · 03/04 09:39
Endo to pay over $1.45B to feds to settle misbranding opioid charge
Seeking Alpha · 02/29 18:46
Press Release: Opioid Manufacturer Endo Health -2-
Dow Jones · 02/29 16:31
Press Release: Opioid Manufacturer Endo Health Solutions Inc. Agrees to Global Resolution of Criminal and Civil Investigations into Sales and Marketing of Branded Opioid Drug
Dow Jones · 02/29 16:31
*DOJ: Endo Health Solutions Agrees to Civil Settlement of $475.6 Million
Dow Jones · 02/29 16:29
*DOJ: Endo Health Solutions Agrees to Plead Guilty in Federal Court to One-Count Misdemeanor Information
Dow Jones · 02/29 16:29
*DOJ: U.S. to Get Up to $464.9 Million Over 10 Years Under Endo Bankruptcy Agreement
Dow Jones · 02/29 16:27
*DOJ: U.S. Also Reaches Settlement with Endo International in Bankruptcy Case
Dow Jones · 02/29 16:25
Weekly Report: what happened at ENDPQ last week (0219-0223)?
Weekly Report · 02/26 09:42
More
Webull provides a variety of real-time ENDPQ stock news. You can receive the latest news about Endo Intl Plc through multiple platforms. This information may help you make smarter investment decisions.
About ENDPQ
Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection. The Company's Generic Pharmaceuticals segment consists of a product portfolio, including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic and sprays.